Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,521 to 1,540 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway-Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B. | Cancer Discov | 2021 | 34301793 | PubTator, text mining | PubMed |
| Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond. | J Hematol Oncol | 2021 | 34301270 | PubTator, text mining | PubMed |
| Functional Roles of Bromodomain Proteins in Cancer. | Cancers (Basel) | 2021 | 34298819 | PubTator, text mining | PubMed |
| The Cancer-Immunity Cycle in Multiple Myeloma. | Immunotargets Ther | 2021 | 34295843 | PubTator, text mining | PubMed |
| E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points. | Front Chem | 2021 | 34291038 | PubTator, text mining | PubMed |
| Reversible Covalent PROTACs: Novel and Efficient Targeted Degradation Strategy. | Front Chem | 2021 | 34291036 | PubTator, text mining | PubMed |
| Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities. | Sci Rep | 2021 | 34282158 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Palmitic Acid Augmentation in COVID-19 Pathologies. | Int J Mol Sci | 2021 | 34281182 | PubTator, text mining | PubMed |
| Targeting Protein Kinases Degradation by PROTACs. | Front Chem | 2021 | 34277564 | PubTator, text mining | PubMed |
| Upcoming treatments for morphea. | Immun Inflamm Dis | 2021 | 34272836 | PubTator, text mining | PubMed |
| A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion. | Nat Commun | 2021 | 34272367 | PubTator, text mining | PubMed |
| Renal Mucosa-Associated Lymphoid Tissue (MALT) Associated End-Stage Renal Disease in a Patient Presenting With Diarrhea. | Cureus | 2021 | 34262829 | PubTator, text mining | PubMed |
| Chidamide-Induced Accumulation of Reactive Oxygen Species Increases Lenalidomide Sensitivity Against Multiple Myeloma Cells. | Onco Targets Ther | 2021 | 34262292 | PubTator, text mining | PubMed |
| Finding the optimal partner to pair with bispecific antibody therapy for multiple myeloma. | Blood Cancer Discov | 2021 | 34258583 | PubTator, text mining | PubMed |
| Targeting low-risk myelodysplastic syndrome with novel therapeutic strategies. | Trends Mol Med | 2021 | 34257007 | PubTator, text mining | PubMed |
| [Proteomic analysis of lacrimal gland adenoid cystic carcinoma with high-grade transformation]. | Zhonghua Yan Ke Za Zhi | 2021 | 34256474 | PubTator, text mining | PubMed |
| MEKK1-Dependent Activation of the CRL4 Complex Is Important for DNA Damage-Induced Degradation of p21 and DDB2 and Cell Survival. | Mol Cell Biol | 2021 | 34251884 | PubTator, text mining | PubMed |
| Opportunities and Challenges of Small Molecule Induced Targeted Protein Degradation. | Front Cell Dev Biol | 2021 | 34249939 | PubTator, text mining | PubMed |
| Comparative Genomics Identifies Putative Interspecies Mechanisms Underlying Crbn-Sall4-Linked Thalidomide Embryopathy. | Front Genet | 2021 | 34249098 | PubTator, text mining | PubMed |
| Hepatoblastoma: glutamine depletion hinders cell viability in the embryonal subtype but high GLUL expression is associated with better overall survival. | J Cancer Res Clin Oncol | 2021 | 34235580 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=77